Impact of immunocompromised status on real-world outcomes with avelumab treatment in advanced Merkel cell carcinoma: findings from the prospective MCC-TRIM registry.

Authors

Jürgen C Becker, Seyed Hamidreza Mahmoudpour, Dirk Schadendorf, Ulrike Leiter, Friedegund Meier, Rudolf Herbst, Stephan Grabbe, Christoffer Gebhardt, Fabian Ziller, Claudia Pföhler, Peter Mohr, Lisa Zimmer, Emmanuelle Boutmy, Dina Oksen, Mairead Kearney, Katia Ruth, Sebastian Hoff, Margarita Shlaen, Selma Ugurel

Published in

The British journal of dermatology. Oct 10, 2026. Epub Oct 10, 2026.

PMID:
42855830
Bibliographic data and abstract were imported from PubMed on 10 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.